Onasemnogene abeparvovec Zolgensma and Thrombocytopenia
Result of checking the interaction of drug Onasemnogene abeparvovec Zolgensma and disease Thrombocytopenia for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Transient decreases in platelet counts, some of which met the criteria for thrombocytopenia, were observed at different time points after onasemnogene abeparvovec-xioi infusion. Care should be exercised in patients at risk. It is recommended to monitor platelet counts before the infusion and weekly for the first month; every other week for the second and third months until platelet counts return to baseline as appropriate.
Generic Name: onasemnogene abeparvovec
Brand Name: Zolgensma, Zolgensma
Synonyms: Onasemnogene abeparvovec (Zolgensma), Onasemnogene Abeparvovec